Gynecomastia as a familial incomplete male pseudohermaphroditism type 1: a limited androgen resistance syndrome.
Dihydrotestosterone binding by cultured human fibroblasts. Comparison of cells from control subjects and from patients with hereditary male pseudohermaphroditism due to androgen resistance.
Familial incomplete male pseudohermaphroditism, type 1. Evidence for androgen resistance and variable clinical manifestations in a family with the Reifenstein syndrome.
Androgen insensitivity syndrome: a review.
Delli Paoli E, Di Chiano S, Paoli D, Lenzi A, Lombardo F, Pallotti F.
J Endocrinol Invest. 2023 Nov;46(11):2237-2245. doi: 10.1007/s40618-023-02127-y. Epub 2023 Jun 10.
Androgen insensitivity syndrome.
Hughes IA, Davies JD, Bunch TI, Pasterski V, Mastroyannopoulou K, MacDougall J.
Lancet. 2012 Oct 20;380(9851):1419-28. doi: 10.1016/S0140-6736(12)60071-3. Epub 2012 Jun 13.
Androgen insensitivity syndrome: a review.
Batista RL, Costa EMF, Rodrigues AS, Gomes NL, Faria JA Jr, Nishi MY, Arnhold IJP, Domenice S, Mendonca BB.
Arch Endocrinol Metab. 2018 Mar-Apr;62(2):227-235. doi: 10.20945/2359-3997000000031.
Approach to the Patient: Hirsutism.
Azziz R, Amiri M, Bril F, Joham AE, Kelestimur F, Ottey S, Suturina L, Tay CT, Teede H, Yildiz BO, Zhao X.
J Clin Endocrinol Metab. 2025 Sep 16;110(10):e3503-e3519. doi: 10.1210/clinem/dgaf226.
Complete Androgen Insensitivity Syndrome: From Bench to Bed.
Tyutyusheva N, Mancini I, Baroncelli GI, D'Elios S, Peroni D, Meriggiola MC, Bertelloni S.
Int J Mol Sci. 2021 Jan 27;22(3):1264. doi: 10.3390/ijms22031264.
Androgen resistance.
Hughes IA, Deeb A.
Best Pract Res Clin Endocrinol Metab. 2006 Dec;20(4):577-98. doi: 10.1016/j.beem.2006.11.003.
Metformin use in women with polycystic ovary syndrome (PCOS): Opportunities, benefits, and clinical challenges.
Saadati S, Mason T, Godini R, Vanky E, Teede H, Mousa A.
Diabetes Obes Metab. 2025 Jun;27 Suppl 3(Suppl 3):31-47. doi: 10.1111/dom.16422. Epub 2025 May 6.
Androgen resistance syndromes.
Griffin JE, Leshin M, Wilson JD.
Am J Physiol. 1982 Aug;243(2):E81-7. doi: 10.1152/ajpendo.1982.243.2.E81.
Non-classical congenital adrenal hyperplasia: current insights into clinical implications, diagnosis and treatment.
Loli P, Menotti S, di Filippo L, Giustina A.
Endocrine. 2025 Oct;90(1):1-16. doi: 10.1007/s12020-025-04341-5. Epub 2025 Jul 23.
11-Oxygenated androgens in health and disease.
Turcu AF, Rege J, Auchus RJ, Rainey WE.
Nat Rev Endocrinol. 2020 May;16(5):284-296. doi: 10.1038/s41574-020-0336-x. Epub 2020 Mar 16.
